BDBM50356964 CHEMBL1916215

SMILES: Cc1ccc(cc1)C#Cc1ccc(s1)S(=O)(=O)N(CCN1CCOCC1)[C@@H]1CC=CCN(O)C1=O

InChI Key: InChIKey=OQNMPVNWQUKGKU-HSZRJFAPSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50356964   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
72 kDa type IV collagenase (Homo sapiens (Human))	BDBM50356964 (CHEMBL1916215) Show SMILES Cc1ccc(cc1)C#Cc1ccc(s1)S(=O)(=O)N(CCN1CCOCC1)[C@@H]1CC=CCN(O)C1=O |r,c:31| Show InChI InChI=1S/C25H29N3O5S2/c1-20-5-7-21(8-6-20)9-10-22-11-12-24(34-22)35(31,32)28(15-14-26-16-18-33-19-17-26)23-4-2-3-13-27(30)25(23)29/h2-3,5-8,11-12,23,30H,4,13-19H2,1H3/t23-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	2.40	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated f...				Bioorg Med Chem Lett 21: 6485-90 (2011) Article DOI: 10.1016/j.bmcl.2011.08.068 BindingDB Entry DOI: 10.7270/Q2BP0353
					More data for this Ligand-Target Pair
Matrix metalloproteinase-9 (Homo sapiens (Human))	BDBM50356964 (CHEMBL1916215) Show SMILES Cc1ccc(cc1)C#Cc1ccc(s1)S(=O)(=O)N(CCN1CCOCC1)[C@@H]1CC=CCN(O)C1=O |r,c:31| Show InChI InChI=1S/C25H29N3O5S2/c1-20-5-7-21(8-6-20)9-10-22-11-12-24(34-22)35(31,32)28(15-14-26-16-18-33-19-17-26)23-4-2-3-13-27(30)25(23)29/h2-3,5-8,11-12,23,30H,4,13-19H2,1H3/t23-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.800	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human MMP9 catalytic domain (amino acids 107 to 446) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincu...				Bioorg Med Chem Lett 21: 6485-90 (2011) Article DOI: 10.1016/j.bmcl.2011.08.068 BindingDB Entry DOI: 10.7270/Q2BP0353
					More data for this Ligand-Target Pair